Clinical Trials
72 trialsRisk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography
Yonsei University
CVE-CART
Abramson Cancer Center at Penn Medicine
Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study
Abramson Cancer Center at Penn Medicine
OTT 15-05
Ottawa Hospital Research Institute
Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer
Taichung Veterans General Hospital
HIMALAYAS-P
University Health Network, Toronto
ATOPE
Universidad de Granada
Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
Fondazione Italiana Linfomi - ETS
CARDIOTOX
Oncology Institute of Southern Switzerland
Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy
Connecticut Children's Medical Center
CCTGuide Pilot
Abramson Cancer Center at Penn Medicine
DAPA-AIC
Hawler Medical University
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
CLARITY
The Netherlands Cancer Institute
The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies
University of Virginia
Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses
University of Sao Paulo General Hospital
Optimising Screening for the Cardiotoxic Effects of Cancer Therapy
Barts & The London NHS Trust
CARMA
Cedars-Sinai Medical Center
Cardiac Effects From Radiation Therapy by MRI
University of Colorado, Denver
Cardiovascular Function in Acute Leukemia
Abramson Cancer Center at Penn Medicine
CATCH
Vejle Hospital
Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients
Pontificia Universidad Catolica de Chile
Cardiotoxicity Monitoring With Single-lead Electrocardiogram
I.M. Sechenov First Moscow State Medical University
ECHOS2
Washington University School of Medicine
BACCARAT
Institut de Radioprotection et de Surete Nucleaire
Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin
University of Nebraska
BRAVEHeart
University of Sydney
AQUA
Istanbul University
CASPER
Istanbul University
RADAF
Istanbul University
AMICI
Assistance Publique - Hôpitaux de Paris
MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum
Wake Forest University Health Sciences
ONCORE
Hospital Clinico Universitario de Santiago
CARTCO
University College London Hospitals
EROCA
Groupe Hospitalier Pitie-Salpetriere
Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia
Children's Cancer Hospital Egypt 57357
Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity
University of Minnesota
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Mayo Clinic
Cardiocare
A.O.U. Città della Salute e della Scienza
Remote Ischaemic Preconditioning in Childhood Cancer
The University of Hong Kong
ANKE
Heinrich-Heine University, Duesseldorf
CA2D
University Hospital, Bordeaux
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
University of South Florida
PROTECT
Vanderbilt University Medical Center
Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy
Horus University
Association Between Telomere Length and Cardiac Dysfunction
Air Force Military Medical University, China
Acute Exercise Cardioprotection From Doxorubicin
University of British Columbia
CAROLE
Northwell Health
HF-PROACTIVE
Henry Ford Health System